Rankings
▼
Calendar
RCKT Q1 2023 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$572M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$62M
Net Income
-$58M
EPS (Diluted)
$-0.69
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$58M
Free Cash Flow
-$61M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$515M
Total Liabilities
$56M
Stockholders' Equity
$459M
Cash & Equivalents
$65M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$62M
-$43M
-46.1%
Net Income
-$58M
-$43M
-35.7%
← FY 2023
All Quarters
Q2 2023 →